| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Tarsus Pharmaceuticals, Inc. (TARS) has 12 insiders with recent SEC Form 4 filings, including 0 buys and 20 sells. TARS is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 858.5K | $52.55M | - | |
| Dir | 128.8K | $7.89M | - | |
| COO | 79.2K | $4.85M | - | |
| Other | 47.6K | $2.91M | - | |
| Other | 36.7K | $2.25M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep 1, 2021 | Azamian Bobak R.45 | President And CEO | Sell | 5,833 | $25.25 | $147,300.79 | -0.2% | +4.3% | -39.9% | |
| Sep 1, 2021 | Ackermann Michael76 | Director | Sell | 5,833 | $25.24 | $147,236.59 | -0.5% | +4.3% | -39.9% | |
| Aug 11, 2021 | Ackermann Michael76 | Director | Sell | 621 | $25.15 | $15,619.39 | - | +10.1% | -30.9% | |
| Aug 11, 2021 | Azamian Bobak R.45 | President And CEO | Sell | 2,020 | $25.07 | $50,636.11 | - | +10.1% | -30.9% | |
| Aug 9, 2021 | Azamian Bobak R.45 | President And CEO | Sell | 2,443 | $25.01 | $61,088.00 | - | +14.8% | -27.8% | |
| Aug 9, 2021 | Ackermann Michael76 | Director | Sell | 3,829 | $25.00 | $95,725.00 | -0.2% | +14.8% | -27.8% | |
| Aug 5, 2021 | Ackermann Michael76 | Director | Sell | 1,383 | $25.00 | $34,576.50 | - | +11.1% | -31.5% | |
| Aug 5, 2021 | Azamian Bobak R.45 | President And CEO | Sell | 1,370 | $25.00 | $34,250.00 | -0.1% | +11.1% | -31.5% | |
| Jun 25, 2021 | Vivo Capital Ix, LLC57 | 10% Owner | Sell | 55,684 | $29.79 | $1,658,842.40 | -0.6% | -22.5% | -48.0% | |
| Jun 22, 2021 | Vivo Capital Ix, LLC57 | 10% Owner | Sell | 201,620 | $29.05 | $5,856,114.00 | -3.2% | -24.7% | -51.5% |